top of page
Phase 1/2 rGBM
SonALAsense is now recruiting for a Phase 1/2 dose escalation and expansion study of sonodynamic therapy with SONALA-001 in combination with Exablate 4000 Type 2.0 MR-Guided
Focused Ultrasound (MRgFUS) in subjects with progressive or recurrent glioblastoma multiforme
For more details regarding the study design, please visit our ClinicalTrials.gov listing:
This trial is now recruiting, Contact Us to learn more about eligibility.
bottom of page